v3.25.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash Flows From Operating Activities:      
Net earnings/(loss) $ 7,055 $ (8,933) $ 8,040
Adjustments to reconcile net earnings/(loss) to net cash provided by operating activities:      
Depreciation and amortization, net 4,011 9,600 9,760
Deferred income taxes (965) (2,089) (3,288)
Stock-based compensation 553 507 518
Impairment charges 1,098 2,963 255
Divestiture gains and royalties (1,165) (1,119) (884)
Acquired IPRD 3,721 13,373 913
Equity investment (gains)/losses, net (280) (16) 160
Contingent consideration fair value adjustments 351 0 0
Other adjustments 232 94 300
Changes in operating assets and liabilities:      
Receivables (295) 264 (995)
Inventories (184) (486) (751)
Accounts payable (2) 184 198
Rebates and discounts (441) 1,484 904
Income taxes payable (4) (1,260) (603)
Other 471 624 (667)
Net cash provided by operating activities 14,156 15,190 13,860
Cash Flows From Investing Activities:      
Sale and maturities of marketable debt securities 1,975 1,122 733
Purchase of marketable debt securities (2,000) (769) (1,774)
Proceeds from sales of equity investments 77 265 215
Capital expenditures (1,311) (1,248) (1,209)
Divestiture and other proceeds 1,071 1,099 909
Acquisition and other payments, net of cash acquired (3,944) (21,821) (1,169)
Net cash provided by/(used in) investing activities (4,132) (21,352) (2,295)
Cash Flows From Financing Activities:      
Proceeds from issuance of short-term debt obligations 0 2,987 0
Repayments of short-term debt obligations 0 (3,000) 0
Other short-term financing obligations, net 25 99 (120)
Proceeds from issuance of long-term debt 5,740 12,883 4,455
Repayments of long-term debt (10,940) (2,873) (3,879)
Repurchase of common stock 0 0 (5,155)
Dividends (5,045) (4,863) (4,744)
Stock option proceeds and other, net (128) (106) 27
Net cash provided by/(used in) financing activities (10,348) 5,127 (9,416)
Effect of exchange rates on cash, cash equivalents and restricted cash 195 (137) 45
Increase/(decrease) in cash, cash equivalents and restricted cash (129) (1,172) 2,194
Cash, cash equivalents and restricted cash at beginning of period 10,347 11,519 9,325
Cash, cash equivalents and restricted cash at end of period $ 10,218 $ 10,347 $ 11,519